RECENT NEWS
05.21.13
Regulus to Present at Deutsche Bank 38th Annual Healthcare Conference »
05.14.13
Regulus Provides Update on 'Road to the Clinic' Strategy and Reports First Quarter 2013 Financial Results and Recent Highlights »
05.21.13
Regulus to Present at Deutsche Bank 38th Annual Healthcare Conference »
05.14.13
Regulus Provides Update on 'Road to the Clinic' Strategy and Reports First Quarter 2013 Financial Results and Recent Highlights »
Regulus is a leading company focused
on the discovery and development of
microRNA therapeutics.
LEARN MORE »
on the discovery and development of
microRNA therapeutics.
LEARN MORE »
Regulus is advancing microRNA
therapeutics across several areas,
with a particular focus on fibrosis,
hepatitis C virus (HCV) infection,
immuno-inflammatory diseases,
metabolic diseases, and oncology.
LEARN MORE »
therapeutics across several areas,
with a particular focus on fibrosis,
hepatitis C virus (HCV) infection,
immuno-inflammatory diseases,
metabolic diseases, and oncology.
LEARN MORE »
Regulus uniquely combines leading
biology with proprietary chemistry and
bioinformatics to discover and develop
microRNA therapeutics in key disease
areas of high unmet medical need.
LEARN MORE »
biology with proprietary chemistry and
bioinformatics to discover and develop
microRNA therapeutics in key disease
areas of high unmet medical need.
LEARN MORE »